EXPLORE THE EFFICACY AND SAFETY OF ONCE-DAILY ORAL RIVAROXABAN FOR THE PREVENTION OF CARDIOVASCULAR EVENTS IN PATIENTS WITH NON- VALVULAR ATRIAL FIBRILLATION SCHEDULED FOR CARDIOVERSION. Russian Sklifosovsky Journal "Emergency Medical Care". 2014;(4):66-67. (In Russ.)
Email this article (Login required)
Email the author (Login required) N.V. Sklifosovsky Research Institute for Emergency Medicine”
of the Moscow Health Department,
Department of External Scientific Communications,
Tel.: +7 (495) 620-11-00,
Fax: +7 (495) 628-22-55,
e-mail: mail@jnmp.ru
